소아 관류 제품 시장 요약
As per MRFR analysis, the Pediatric Perfusion Products Market was estimated at 120.55 USD Billion in 2024. The Pediatric Perfusion Products industry is projected to grow from 125.2 USD Billion in 2025 to 182.85 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.86 during the forecast period 2025 - 2035.
주요 시장 동향 및 하이라이트
The Pediatric Perfusion Products Market is experiencing robust growth driven by technological advancements and increasing demand for customized solutions.
- North America remains the largest market for pediatric perfusion products, driven by advanced healthcare infrastructure and high surgical volumes.
- The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and increasing awareness of pediatric health issues.
- Heart-lung machines dominate the market as the largest segment, while extracorporeal membrane oxygenation devices are witnessing rapid growth due to their critical role in complex pediatric cases.
- The increasing number of pediatric cardiac surgeries and a regulatory emphasis on safety standards are key drivers propelling market expansion.
시장 규모 및 예측
| 2024 Market Size | 120.55 (USD 억) |
| 2035 Market Size | 182.85 (USD 억) |
| CAGR (2025 - 2035) | 3.86% |
주요 기업
메드트로닉 (미국), 테루모 주식회사 (일본), 게팅 AB (스웨덴), 리바노바 PLC (영국), 소린 그룹 (이탈리아), 카르디오메딕스 (미국), 니프로 주식회사 (일본), 프레제니우스 카비 (독일)

댓글 남기기